61. 自己免疫性溶血性貧血 Autoimmune hemolytic anemia Clinical trials / Disease details

臨床試験数 : 137 / 薬物数 : 127 - (DrugBank : 55) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 153

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-003363-35-IT (EUCTR)	05/07/2018	04/11/2020	Clinical study to assess the safety, tolerability, efficacy and pharmacokinetics of APL-2in patients ...	An open label, prospective, study to assess the safety, tolerability, efficacy and pharmacokinetics ...	Patients affected by Warm Antibody Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (C ...	Product Name: APL-2 Product Code: APL-2 INN or Proposed INN: APL-2 Product Name: APL-2 Product Code: APL ...	APELLIS PHARMACEUTCIALS, INC.	NULL	Not Recruiting			Female: yes Male: yes	12	Phase 2	United States;Italy
2	NCT03226678 (ClinicalTrials.gov)	August 31, 2017	7/7/2017	Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2in Patients With Warm Type Autoimm ...	An Open Label, Prospective, Study to Assess the Safety, Tolerability, Efficacy and Pharmacokinetics ...	Warm Autoimmune Hemolytic Anemia;Cold Agglutinin Disease	Drug: APL-2	Apellis Pharmaceuticals, Inc.	NULL	Active, not recruiting	18 Years	N/A	All	24	Phase 2	United States

First Previous1Next Last